Read + Share
Spiliotis II, Chalk R, Gough S, Rorsman P, et al. Reducing hyperglucagonemia in type 2 diabetes using low dose Glibenclamide:
Results of the LEGEND-A pilot study. Diabetes Obes Metab 2022 May 1. doi: 10.1111/dom.14740.
PMID: 35491519
|
 |
|
Spiliotis II, Chalk R, Gough S, Rorsman P, et al. Reducing hyperglucagonemia in type 2 diabetes using low dose Glibenclamide:
Results of the LEGEND-A pilot study. Diabetes Obes Metab 2022 May 1. doi: 10.1111/dom.14740.
PMID: 35491519
|
|
|
|